Competitive Problems in the Drug Industry, 5. sējums,22. daļa;22. sējumsU.S. Government Printing Office, 1972 |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
500 mg Tablets Acid agency analgesic antibiotic approved aspirin available for public Chairman Chloride Chlorpheniramine Maleate clinical Codeine Committee Company confidential cost Cream Darvon data and information deleted dosage DPSC Drug Administration drug items drug products E. R. Squibb effective drugs Erythromycin ethoheptazine evaluation Food and Drug formulary GORDON Gram GUAIACOLATE hexachlorophene hospital Hydrochloride HYDROCORTISONE Ilosone ineffective labeling Laboratories Lederle Lederle Laboratories Maleate manufacturers Medicaid medicare mg Capsules mg per ml ml Contains ml Injection Neomycin Ointment Opth Oral Suspension patients Penicillin pentazocine percent Pfizer Pharmaceutical Pharmacy Phenacetin Phenobarbital PHENYLEPHRINE physicians Polymyxin possibly effective prescribing prescription drugs procurement propoxyphene public disclosure purchase request SEGGEL Senator NELSON Service SODIUM specific STAATS submitted Sulfacetamide Sulfate Syrup Tablet Contains testing THEOPHYLLINE Therapeutic Agents therapy tion tolbutamide Units Upjohn Vitamin Wyeth
Populāri fragmenti
8773. lappuse - As used in this subsection and subsection (e), the term "substantial evidence" means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended,...
8798. lappuse - ... representations made or suggested by statement, word, design, device, sound, or any combination thereof, but also the extent to which the advertisement fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the commodity to which the advertisement relates under the conditions prescribed in said advertisement, or under such conditions as are customary or usual.
8851. lappuse - The using by any person to his own advantage, or revealing, other than to the Secretary or officers or employees of the Department, or to the courts when relevant in any judicial proceeding under this Act, any information acquired under authority of section 404, 409, 505, 506, 507, 704 or 706 concerning any method or process which as a trade secret is entitled to protection.
8851. lappuse - ... referred to in section 1905 of title 18 of the United States Code, shall be considered confidential for the purpose of that section, except that such information may be disclosed to other officers or employees concerned with carrying out this Act or when relevant in any proceeding under this Act.
8851. lappuse - Whoever, being an officer or employee of the United States or of any department or agency thereof...
8857. lappuse - A trade secret may consist of any formula, pattern, device or compilation of information which is used in one's business, and which gives him an opportunity to obtain an advantage over competitors who do not know or use it.
8851. lappuse - ... any income return or copy thereof or any book containing any abstract or particulars thereof to be seen or examined by any person except as provided by law...
8851. lappuse - All information reported to or otherwise obtained by, the Secretary or the Secretary of the department in which the Coast Guard is operating or their representatives pursuant to this subsection which contains or relates to a trade secret or other matter referred to...
8795. lappuse - Attached hereto, In triplicate, and constituting a part of this petition, are the following: A. The name and all pertinent Information concerning the food additive, including chemical identity and composition of the food additive.
8787. lappuse - The Committee on Fetus and Newborn of the American Academy of Pediatrics...